Abraxis BioScience, Inc. (NASDAQ: ABII) reports Q3 adj-EPS of $0.21, compared to a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE